Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical and Biomedical Analysis|July 10, 2020
Development of a direct LC-ESI-MS method for the measurement of human serum carnosinase activityEttore Gilardoni, Silvia Gervasoni, Marco Maspero, et al.
Scientific Reports|March 24, 2023
Molecular simulations of SSTR2 dynamics and interaction with ligandsSilvia Gervasoni, Camilla Guccione, Viviana Fanti, et al.
Nutrients|May 14, 2022
Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing DipeptidesLuca Regazzoni, Laura Fumagalli, Angelica Artasensi, et al.
Scientific Reports|August 8, 2019
Dual-active antifungal agents containing strobilurin and SDHI-based pharmacophoresMarco Zuccolo, Andrea Kunova, Loana Musso, et al.
International Journal of Molecular Sciences|January 11, 2024
Target Prediction by Multiple Virtual Screenings: Analyzing the SARS-CoV-2 Phenotypic Screening by the Docking Simulations Submitted to the MEDIATE InitiativeSilvia Gervasoni, Candida Manelfi, Sara Adobati, et al.
Communications Biology|October 19, 2023
Structure of human TRPM8 channelSergii Palchevskyi, Mariusz Czarnocki-Cieciura, Giulio Vistoli, et al.
Journal of Chemical Information and Modeling|November 8, 2021
Multiscale Workflow for Modeling Ligand Complexes of Zinc MetalloproteinsZongfan Yang, Rebecca M Twidale, Silvia Gervasoni, et al.
Journal of Medicinal Chemistry|October 6, 2022
Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101Angelica Artasensi, Andrea Angeli, Carmen Lammi, et al.
International Journal of Molecular Sciences|July 26, 2020
A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0Silvia Gervasoni, Giulio Vistoli, Carmine Talarico, et al.
ACS Chemical Neuroscience|September 16, 2021
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System DisordersAlessandro Bonifazi, Amy H Newman, Thomas M Keck, et al.
Pageof 4